Records 1 - 4
| Mutational Characterization and Potential Prognostic Biomarkers of Chinese Patients with Esophageal Squamous Cell Carcinoma.
OncoTargets and therapy 2020 13 12797-12809.
Zhang Nan, Shi Junping, Shi Xiaoliang, Chen Wenting, Liu Junfe
| Increased FGF19 copy number is frequently detected in hepatocellular carcinoma with a complete response after sorafenib treatment.
Oncotarget 2016 Aug 7 (31): 49091-49098.
Kaibori Masaki, Sakai Kazuko, Ishizaki Morihiko, Matsushima Hideyuki, De Velasco Marco A, Matsui Kosuke, Iida Hiroya, Kitade Hiroaki, Kwon A-Hon, Nagano Hiroaki, Wada Hiroshi, Haji Seiji, Tsukamoto Tadashi, Kanazawa Akishige, Takeda Yutaka, Takemura Shigekazu, Kubo Shoji, Nishio Kazu
| Identification of FGF19 as a prognostic marker and potential driver gene of lung squamous cell carcinomas in Chinese smoking patients.
Oncotarget 2016 Mar .
Li Fan, Xia Weiliang, Wang Guan, Tan Qiang, Li Ziming, Niu Xiaomin, Ji Wenxiang, Yuan Hong, Xu Qiang, Luo Qingquan, Zhang Jie, Lu Sh
| Identification of novel therapeutic targets in the PI3K/AKT/mTOR pathway in hepatocellular carcinoma using targeted next generation sequencing.
Oncotarget 2014 May 5 (10): 3012-22.
Janku Filip, Kaseb Ahmed O, Tsimberidou Apostolia M, Wolff Robert A, Kurzrock Razel